Scientific paper - Case study
Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach
Frontiers in Oncology, 7 (2017); 77. https://doi.org/10.3389/fonc.2017.00077


Cite this document

Krušlin, B., Tomas, D., Džombeta, T., Milković Periša, M. & Ulamec, M. (2017). Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach. Frontiers in Oncology, 7., 77. doi: 10.3389/fonc.2017.00077

Krušlin, Božo, et al. "Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach." Frontiers in Oncology, vol. 7, 2017, p. 77. https://doi.org/10.3389/fonc.2017.00077

Krušlin, Božo, Davor Tomas, Tihana Džombeta, Marija Milković Periša and Monika Ulamec. "Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach." Frontiers in Oncology 7 (2017): 77. https://doi.org/10.3389/fonc.2017.00077

Krušlin, B., et al. (2017) 'Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach', Frontiers in Oncology, 7, p. 77. doi: 10.3389/fonc.2017.00077

Krušlin B, Tomas D, Džombeta T, Milković Periša M, Ulamec M. Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach. Frontiers in Oncology [Internet]. 2017 April 25 [cited 2024 June 18];7:77. doi: 10.3389/fonc.2017.00077

B. Krušlin, D. Tomas, T. Džombeta, M. Milković Periša and M. Ulamec, "Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach", Frontiers in Oncology, vol. 7, p. 77, April 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:485663. [Accessed: 18 June 2024]